SPAC2F3.14c Antibody

What is SPAC2F3.14c and why is it important in research?

SPAC2F3.14c (also known as Saf2) is an essential gene in Schizosaccharomyces pombe encoding a WW domain-containing protein involved in pre-mRNA splicing. It was identified as a component of splicing complexes through systematic two-hybrid and comparative proteomic analyses . The protein is essential for cell viability, as deletion of SPAC2F3.14c from the genome results in lethality, with spores typically arresting in the first cell cycle after germination . RT-PCR analyses of RNA isolated from these germinated spores demonstrated that Saf2 is required for pre-mRNA splicing . Understanding this protein and developing tools to study it are crucial for elucidating splicing mechanisms in fission yeast, which serve as models for more complex eukaryotic systems.

What is the molecular function of the SPAC2F3.14c protein?

SPAC2F3.14c/Saf2 functions as a splicing associated factor in S. pombe. It was identified in Prp19-TAP (Tandem Affinity Purification) complexes through proteomics analyses, indicating its role in the spliceosome. Specifically, it associates with splicing factors and interacts with Dre4 and Prp19, which are components of the NTC (nineteen complex) . The protein contains a WW domain, which typically mediates protein-protein interactions through recognition of proline-rich sequences. Immunoprecipitation experiments confirmed its interactions with splicing machinery components . Additionally, the deletion of SPAC2F3.14c/Saf2 demonstrated that it is specifically required for pre-mRNA splicing, as shown by accumulation of unspliced transcripts in deletion mutants .

How is SPAC2F3.14c related to other splicing factors in S. pombe?

SPAC2F3.14c/Saf2 was identified alongside SPAC1782.03/Saf3 as essential splicing factors in S. pombe through TAP purification of NTC components . Both proteins associate with many splicing factors as revealed by 2D-LC mass spectrometric analysis. Standard co-immunoprecipitations validated their interactions with Dre4 and Prp19 . Saf2 is considerably less abundant than other splicing factors like Prp17 (approximately 55-fold less abundant as determined by quantitative immunoblotting), suggesting it is not a core NTC component but rather plays a regulatory or specialized role in splicing . This interaction network places SPAC2F3.14c within the broader context of the splicing machinery in fission yeast.

How can I validate the specificity of anti-SPAC2F3.14c antibodies for my research?

Validating antibody specificity for SPAC2F3.14c requires multiple approaches:

• Knockout/Deletion Controls: Use SPAC2F3.14c deletion strains as negative controls (though these may be inviable for extended periods). Alternatively, use conditional knockdowns (e.g., via thiamine-repressible promoters) to create samples with reduced SPAC2F3.14c expression .

• Western Blot Analysis: Perform western blotting using the antibody on wild-type and conditional knockdown samples. A specific antibody should show reduced signal intensity in the knockdown samples .

• IP-MS Validation: Perform immunoprecipitation followed by mass spectrometry to confirm that the antibody pulls down SPAC2F3.14c and its known interacting partners like Dre4 and Prp19 .

• Epitope Tagging: Create strains with epitope-tagged SPAC2F3.14c (GFP, HA, or TAP) and use well-characterized antibodies against these tags to compare with your SPAC2F3.14c antibody staining patterns .

• Peptide Competition: Pre-incubate the antibody with the immunizing peptide before application to samples, which should block specific binding .

Remember that antibody validation must be performed in the specific experimental context where it will be used, as an antibody may work for western blotting but not for immunofluorescence or vice versa .

What are the critical differences between polyclonal and monoclonal antibodies against SPAC2F3.14c?

The choice between polyclonal and monoclonal anti-SPAC2F3.14c antibodies depends on research objectives:

Polyclonal Antibodies:

• Commercial options include rabbit anti-Schizosaccharomyces pombe SPAC2F3.14c antibodies

• Recognize multiple epitopes on SPAC2F3.14c, increasing sensitivity but potentially reducing specificity

• More robust against minor protein denaturation or conformation changes

• May exhibit batch-to-batch variation requiring revalidation

• Suitable for applications detecting native proteins (IP, IF) and denatured proteins (WB)

Monoclonal Antibodies:

• Recognize a single epitope on SPAC2F3.14c

• Highly consistent across different lots with minimal batch variation

• May be less sensitive than polyclonals but more specific

• Could be rendered ineffective if the single epitope is masked or altered

• Valuable for distinguishing specific protein conformations or modifications

For specialized applications like quantitative immunofluorescence studies of SPAC2F3.14c localization during cell cycle phases, monoclonals may provide more consistent results. For general detection in multiple applications, polyclonals offer flexibility .

What controls should I include when using anti-SPAC2F3.14c antibodies in immunoblotting?

Proper controls for SPAC2F3.14c immunoblotting include:

Essential Controls:

• Positive Control: Wild-type S. pombe lysate expressing normal levels of SPAC2F3.14c

• Negative Control: When possible, conditional knockdown of SPAC2F3.14c (as complete knockouts are lethal)

• Loading Control: Antibody against a stable reference protein (e.g., α-tubulin or GAPDH)

• Molecular Weight Marker: To confirm the band appears at the expected molecular weight (~32 kDa for SPAC2F3.14c)

Additional Recommended Controls:
5. Epitope-Tagged Control: Lysate from cells expressing tagged SPAC2F3.14c (e.g., SPAC2F3.14c-GFP, SPAC2F3.14c-TAP) to compare migration patterns
6. Blocking Peptide Control: Pre-incubate antibody with immunizing peptide to demonstrate specificity
7. Secondary Antibody-Only Control: To detect non-specific binding of secondary antibody
8. Deglycosylation Treatment: If SPAC2F3.14c glycosylation affects antibody recognition, compare untreated and deglycosylated samples

When analyzing interaction partners, additional controls to consider include immunoprecipitation with IgG from non-immunized animals and reciprocal co-immunoprecipitations with antibodies against known interaction partners like Dre4 or Prp19 .

How can I optimize immunoprecipitation protocols using anti-SPAC2F3.14c antibodies?

For optimal immunoprecipitation of SPAC2F3.14c, consider these methodological adaptations:

Optimized IP Protocol:

• Cell Lysis Conditions: Use NP-40 lysis buffer for native conditions or denaturing conditions depending on your experimental needs. For splicing complex analysis, native conditions are preferable .

• Extract Preparation: Flash-freeze cell pellets in dry ice/ethanol bath before lysis by bead disruption, which helps preserve protein complexes .

• Antibody Amount Optimization: Titrate antibody amounts (typically 1-5 μg per mg of total protein) to determine optimal ratio for SPAC2F3.14c capture.

• Pre-clearing Step: Pre-clear lysates with Protein G or Protein A beads to reduce non-specific binding.

• Binding Conditions: Incubate antibody with lysate for 1-2 hours at 4°C followed by addition of beads for another hour .

• Washing Stringency: Perform at least 3 washes with binding buffer containing 5 mM imidazole to reduce background while maintaining specific interactions .

• Elution Options: For downstream mass spectrometry analysis, elute with 2X SDS sample buffer or use a gentler elution with peptide competition if maintaining native complexes is necessary.

• Controls: Include immunoprecipitation with non-specific IgG and, if possible, perform reciprocal IPs with antibodies against known SPAC2F3.14c interaction partners like Dre4 or Prp19 .

This protocol can be further optimized by comparing results from anti-SPAC2F3.14c antibodies with results from tagged versions of SPAC2F3.14c (GFP-tagged or TAP-tagged) immunoprecipitated with anti-tag antibodies .

What are the best methods for detecting SPAC2F3.14c in fixed S. pombe cells?

For detecting SPAC2F3.14c in fixed S. pombe cells, consider these methodological approaches:

Immunofluorescence Protocol Optimization:

• Fixation Method: For splicing factors like SPAC2F3.14c, methanol fixation (-20°C, 8 minutes) often preserves nuclear structures better than formaldehyde for detecting nuclear splicing complexes.

• Cell Wall Digestion: Proper spheroplasting is critical. Use zymolyase at 5-10 mg/ml for 10-30 minutes at 37°C, and monitor by phase contrast microscopy .

• Permeabilization: Use 1% Triton X-100 in PBS for 5 minutes to ensure antibody access to nuclear splicing factors.

• Blocking: Block with 5% BSA or 5% normal serum from the secondary antibody host species for at least 60 minutes.

• Antibody Dilution: Start with 1:100-1:500 dilutions of primary anti-SPAC2F3.14c antibody and optimize as needed. Incubate overnight at 4°C for maximum sensitivity.

• Co-localization Markers: Co-stain with antibodies against known splicing factors (e.g., Prp19) to confirm correct localization pattern.

• Mounting Media: Use mounting media containing DAPI to visualize nuclei and anti-fade reagent to prevent photobleaching.

• Confocal Imaging: Use confocal microscopy for better resolution of nuclear structures and co-localization with other splicing factors.

Given SPAC2F3.14c's relatively low abundance , signal amplification methods may be necessary, such as using fluorophore-conjugated secondary antibodies with higher fluorophore-to-antibody ratios or employing tyramide signal amplification systems.

How can I use anti-SPAC2F3.14c antibodies to study splicing dynamics during the cell cycle?

To study SPAC2F3.14c's role in splicing dynamics throughout the cell cycle:

Experimental Approach:

• Cell Synchronization: Synchronize S. pombe cultures using methods like lactose gradient centrifugation, nitrogen starvation, or cdc25-22 temperature-sensitive mutants.

• Time-Course Sampling: Collect samples at regular intervals (every 15-20 minutes) throughout the cell cycle.

• Dual Immunostaining: Co-stain for SPAC2F3.14c and cell cycle markers (e.g., Sid4 for SPB, Psy1 for forespore membrane) .

• Quantitative Analysis:

  • Measure SPAC2F3.14c levels by western blotting, normalizing to loading controls

  • Quantify SPAC2F3.14c localization patterns by fluorescence intensity measurements in different cellular compartments

  • Track co-localization coefficients with other splicing factors

• Splicing Assay: Pair protein analysis with RT-PCR of reporter genes containing introns to correlate SPAC2F3.14c dynamics with splicing efficiency .

• Genetic Background Variation: Compare wild-type cells with mutants in other splicing factors or cell cycle regulators to identify genetic interactions.

• Live Cell Imaging: For dynamic studies, combine antibody-based fixed cell analysis with live imaging of GFP-tagged SPAC2F3.14c.

This comprehensive approach will reveal how SPAC2F3.14c localization, abundance, and interaction patterns change throughout the cell cycle, providing insights into the regulation of splicing during different cell cycle phases.

What are common issues when using anti-SPAC2F3.14c antibodies and how can they be resolved?

When working with anti-SPAC2F3.14c antibodies, researchers may encounter these common issues:

Problem: High Background in Western Blots

• Solution: Increase blocking time (1-2 hours), use 5% milk or BSA in TBST, increase washing steps (5x 5 minutes), and optimize antibody dilution (try 1:1000-1:5000).

• Advanced Fix: Try alternative blockers like fish gelatin or commercially available blockers specifically designed for yeast proteins.

Problem: No Signal in Immunoprecipitation

• Solution: Ensure proper cell lysis (check microscopically), protect samples from proteases (use fresh inhibitors), and verify antibody binding capacity (protein A/G beads might have reduced binding to certain IgG subclasses).

• Advanced Fix: Cross-link antibodies to beads using dimethyl pimelimidate to prevent antibody leaching during elution.

Problem: Multiple Bands in Western Blot

• Solution: Validate with tagged SPAC2F3.14c controls, optimize SDS-PAGE conditions (try gradient gels), and check for post-translational modifications by treatment with phosphatases or glycosidases .

• Advanced Fix: Perform peptide competition assays to identify which bands are specific.

Problem: Weak Signal in Immunofluorescence

• Solution: Optimize fixation (try different methods), increase antibody concentration, extend incubation time (overnight at 4°C), and use signal amplification methods.

• Advanced Fix: Try antigen retrieval methods adapted for yeast cells or use super-resolution microscopy techniques for better visualization of nuclear proteins.

Problem: Inconsistent Results Between Experiments

• Solution: Standardize protocols meticulously, prepare fresh buffers regularly, use the same antibody lot when possible, and include positive controls in each experiment.

• Advanced Fix: Consider developing a standard operating procedure with quantitative quality control metrics for each batch of experiments.

SPAC2F3.14c's relatively low abundance compared to other splicing factors (~55-fold less abundant than Prp17) makes detection particularly challenging, requiring careful optimization of all protocols.

How do different sample preparation methods affect anti-SPAC2F3.14c antibody performance?

Sample preparation significantly impacts anti-SPAC2F3.14c antibody performance:

Cell Lysis Methods Comparison:

• Mechanical Disruption (glass beads or French press):

  • Advantage: Complete lysis ensuring maximum SPAC2F3.14c extraction

  • Disadvantage: May disrupt protein complexes and generate heat

  • Best for: Total protein analysis, western blotting

• Enzymatic Spheroplasting (zymolyase treatment):

  • Advantage: Gentler preservation of protein complexes

  • Disadvantage: Incomplete lysis, enzyme batch variability

  • Best for: Immunoprecipitation of intact complexes, immunofluorescence

• Freeze-Thaw Cycles:

  • Advantage: Simple, requires minimal equipment

  • Disadvantage: Inconsistent lysis, potential protein degradation

  • Best for: Quick screening assays

Buffer Composition Considerations:

• Salt Concentration: Higher salt (>150mM NaCl) may reduce antibody-antigen binding but decrease non-specific interactions

• Detergent Selection: NP-40 (0.1-1%) works well for membrane-associated complex isolation

• pH Optimization: Test pH 7.0-8.0 range for optimal antibody-antigen interaction

• Protease Inhibitors: Essential due to SPAC2F3.14c's low abundance; use fresh, complete cocktails

Protein Denaturation Effects:

• Native Conditions: Necessary for studying SPAC2F3.14c interactions; preserve complexes with Prp19 and Dre4

• Denaturing Conditions: May expose epitopes for better detection in western blots but destroy complex information

For optimal results, match sample preparation method to the specific application, and validate each method empirically for your specific anti-SPAC2F3.14c antibody.

What techniques can improve sensitivity when detecting low abundance SPAC2F3.14c protein?

Detecting SPAC2F3.14c, which is approximately 55-fold less abundant than other splicing factors like Prp17 , requires specialized sensitivity-enhancing techniques:

Signal Amplification Strategies:

• Enhanced Chemiluminescence (ECL) Optimization:

  • Use high-sensitivity ECL substrates (SuperSignal West Femto or similar)

  • Extend exposure times (up to overnight with cooled cameras)

  • Use stacked film technique for western blots

• Fluorescence-Based Detection:

  • Use far-red fluorophores (IRDye800) for lower background

  • Apply dual-color infrared imaging systems (like Odyssey) which offer superior quantitative range

  • Quantify protein intensities using specialized software (e.g., Odyssey version 1.2)

• Immunoprecipitation Enrichment:

  • Concentrate SPAC2F3.14c by immunoprecipitation before detection

  • Scale up starting material (5-10x normal amounts)

  • Use tandem affinity purification for cleaner preparations

• Proximity Ligation Assay (PLA):

  • Employs rolling circle amplification to visualize protein interactions

  • Can detect single molecules of SPAC2F3.14c in situ

  • Especially useful for studying interactions with Dre4, Prp19, or other splicing factors

• Sample Loading Optimization:

  • Load maximum protein per lane (50-100 μg)

  • Use gradient gels for better protein separation

  • Apply fractionation techniques to enrich nuclear proteins

Technical Protocol Adjustments:

• Extend primary antibody incubation to overnight at 4°C

• Reduce washing stringency slightly to preserve antibody binding

• Use protein concentration methods like TCA precipitation before loading

• Consider tyramide signal amplification for immunofluorescence applications

These approaches have been successfully applied to detect other low-abundance splicing factors and can be adapted specifically for SPAC2F3.14c detection .

How can SPAC2F3.14c antibodies be used to investigate stress responses in splicing?

SPAC2F3.14c antibodies can provide valuable insights into stress-induced changes in splicing regulation:

Experimental Design for Stress Response Studies:

• Stress Condition Panel:

  • Oxidative stress (H₂O₂ treatment)

  • Heat shock (temperature shift to 39-42°C)

  • Osmotic stress (sorbitol or KCl)

  • Nutritional stress (nitrogen or glucose deprivation)

  • DNA damage (UV exposure or MMS treatment)

• Time-Course Analysis:

  • Monitor SPAC2F3.14c levels, localization, and complex formation at multiple timepoints (0, 15, 30, 60, 120 min)

  • Collect synchronized cells to control for cell cycle effects

• Co-immunoprecipitation Under Stress:

  • Use anti-SPAC2F3.14c antibodies to pull down associated complexes

  • Compare interaction partners under normal versus stress conditions

  • Quantify changes in complex composition by mass spectrometry

• Chromatin Association Analysis:

  • Perform chromatin immunoprecipitation (ChIP) with anti-SPAC2F3.14c antibodies

  • Analyze association with stress-responsive genes

  • Compare with ChIP data for transcription factors like Atf1 and Pcr1

• Correlation with Splicing Outcomes:

  • Pair protein data with RNA-seq to monitor intron retention rates

  • Target analysis of stress-responsive genes with complex splicing patterns

  • Compare with sty1Δ (stress-activated MAP kinase) mutants

This approach can reveal how stress pathways regulate pre-mRNA splicing through SPAC2F3.14c and related factors, potentially uncovering stress-specific splicing regulation mechanisms in fission yeast.

How can I design experiments to study SPAC2F3.14c interactions with Prp19 complex components?

To study SPAC2F3.14c interactions with Prp19 complex components:

Comprehensive Interaction Analysis Strategy:

• Sequential Co-immunoprecipitation (Co-IP):

  • First IP: Use anti-SPAC2F3.14c antibodies to pull down primary complexes

  • Elution: Gentle elution with peptide competition

  • Second IP: Use antibodies against Prp19 complex components

  • Analysis: Western blot for specific components or mass spectrometry for comprehensive profiling

• Proximity-Based Protein Interaction Mapping:

  • BioID approach: Express SPAC2F3.14c fused to a biotin ligase

  • In vivo biotinylation of proteins in close proximity

  • Streptavidin pull-down followed by mass spectrometry

  • Compare with Prp19-BioID to identify shared and unique interaction partners

• In Vitro Binding Assays:

  • Recombinant protein production: Express His6-tagged SPAC2F3.14c

  • Pull-down assays with yeast lysates containing tagged Prp19 complex components

  • Map binding domains using truncated constructs

  • Measure binding affinities using surface plasmon resonance

• Genetic Interaction Analysis:

  • Construct conditional SPAC2F3.14c mutants (temperature-sensitive or thiamine-repressible)

  • Cross with mutants of Prp19 complex components

  • Analyze genetic interactions (synthetic lethality, suppression)

  • Correlate with biochemical interaction data

• Structural Analysis of Complexes:

  • Cryo-EM of purified complexes containing SPAC2F3.14c and Prp19

  • Cross-linking mass spectrometry to map protein-protein interfaces

  • Integrative modeling combining multiple data sources

This multi-faceted approach will provide comprehensive insights into how SPAC2F3.14c functionally interacts with the Prp19 complex in splicing regulation.

What are the considerations for developing custom anti-SPAC2F3.14c antibodies for specialized applications?

Developing custom anti-SPAC2F3.14c antibodies requires careful planning:

Strategic Considerations:

• Epitope Selection Strategy:

  • Sequence Analysis: Identify unique regions of SPAC2F3.14c not conserved in other WW domain proteins

  • Structural Prediction: Use bioinformatics tools to identify surface-exposed regions

  • Functional Domains: Consider targeting the WW domain for functional studies or unique regions for specific detection

  • Post-translational Modifications: Generate modification-specific antibodies if phosphorylation or other modifications are relevant

• Antigen Design Options:

  • Synthetic Peptides: 15-20 amino acids from unique regions, with terminal cysteine for conjugation

  • Recombinant Protein Fragments: Express 50-150 amino acid fragments as GST or His-tagged fusions

  • Full-length Protein: Express in E. coli, yeast, or baculovirus systems with appropriate tags for purification

• Host Animal Selection:

  • Rabbits: For polyclonal antibodies with high titer and affinity

  • Mice: For monoclonal antibody development via hybridoma technology

  • Chickens: For generating antibodies against conserved mammalian proteins

  • Alpacas: For single-domain antibodies (nanobodies) with unique binding properties

• Validation Requirements:

  • Knockout Controls: Use conditional knockdown of SPAC2F3.14c

  • Overexpression Systems: Test against cells overexpressing tagged SPAC2F3.14c

  • Cross-reactivity Testing: Test against related S. pombe proteins

  • Application-specific Validation: Validate specifically for intended applications (WB, IP, IF, ChIP)

• Production and Purification Considerations:

  • Affinity Purification: Consider antigen-affinity purification for highest specificity

  • Scale: Production in hollow fiber bioreactors for larger quantities

  • Format Options: Whole IgG, Fab fragments, or recombinant antibody fragments depending on application needs

When developing antibodies against low-abundance proteins like SPAC2F3.14c, multiple immunization strategies and extensive validation are essential for success.

What empirical data exists on SPAC2F3.14c localization and abundance across experimental conditions?

Table 1: SPAC2F3.14c/Saf2 Quantitative Characteristics in S. pombe

Table 2: SPAC2F3.14c Detection Methods Comparison

What is the experimental evidence for SPAC2F3.14c protein interactions in splicing complexes?

Table 3: Confirmed SPAC2F3.14c Protein Interactions in S. pombe

Table 5: Comparison of Commercial Antibody Options for SPAC2F3.14c

Table 6: Optimization Parameters for SPAC2F3.14c Antibody Applications